High grade glioma--the arrival of the molecular diagnostic era for patients over the age of 65 years in the UK.

@article{Jefferies2013HighGG,
  title={High grade glioma--the arrival of the molecular diagnostic era for patients over the age of 65 years in the UK.},
  author={S J Jefferies and Frances P Harris and Stephen J. Price and Vincent Peter Collins and Colin Watts},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2013},
  volume={25 7},
  pages={391-3}
}
Population-based data confirm that the incidence of high grade glioma (HGG) (glioblastoma multiforme [GBM] and anaplastic astrocytoma) is greatest in patients over the age of 65 years. The mean age of presentation of GBM is 61.3 14.0 years, with nearly 60% of cases occurring in people over 60 years and the incidence is increasing [1,2]. Age is a prognostic factor in the management of GBM and survival decreases for each decade of life above 50 years [3]. An age of 65 years is used as the… CONTINUE READING